The High flow nasal cannula Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The High flow nasal cannula Market:
https://www.thebusinessresearchcompany.com/report/high-flow-nasal-cannula-global-market-report
According to The Business Research Company’s High flow nasal cannula Global Market Report 2024, The high flow nasal cannula market size has grown rapidly in recent years. It will grow from $5.03 billion in 2023 to $5.61 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising disposable income, changing lifestyle trends, globalization and trade, home renovation and construction activities, e-commerce growth.
The high flow nasal cannula market size is expected to see rapid growth in the next few years. It will grow to $8.23 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to sustainable and eco-friendly products, changing demographics, smart textiles integration, interior design trends, health and wellness textiles. Major trends in the forecast period include smart home integration, sustainable materials and practices, customization and personalization, innovative textile technologies, digital retail experiences.
The rise in asthma and COPD incidence is expected to propel the growth of the high-flow nasal cannula market going forward. Asthma is a disorder in which the airways in the lungs constrict and swell, and excess mucus is produced. COPD, or chronic obstructive pulmonary disease, refers to a set of lung illnesses that make breathing difficult and worsen over time. High-flow nasal cannula has the potential to increase PO2 while minimizing HR and RR and acts as a viable treatment option for individuals suffering from severe bronchial Asthma worsened by respiratory failure. For instance, in April 2023, according to Asthma + Lung UK, a UK-based non-profit organization defending the freedom to breathe, between 2021 and 2022, hospital admissions for children with Asthma surged by 149 percent in England and Wales. Overall, 19,506 children were hospitalised with asthma symptoms between 2020 and 2021, compared with 7,850 between 2020 and 2021. Therefore, the rise in Asthma and COPD incidence is driving the high-flow nasal cannula market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13454&type=smp
The high flow nasal cannula market covered in this report is segmented –
1) By Type: Air Or Oxygen Blenders, Nasal Cannulas, Active Humidifier, Single Heated Tube, Other Types
2) By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Carbon Monoxide Toxicity, Bronchiectasis, Sleep Apnea, Other Applications
3) By Sales Channel: Direct Channel, Distribution Channel
4) By End-User: Hospitals and clinics, Ambulatory care centers, Long-term care centers, Other End-Users
Major companies operating in the high-flow nasal cannula market are focusing on advanced products like the SoftFlow High-Flow Nasal Cannula to provide their existing consumers. The softFlow High-Flow Nasal Cannula is a breathing assistance device that uses a nasal cannula to give warm, humidified, oxygen-enriched oxygen to patients. For instance, in February 2021, Masimo Corporation, a US-based manufacturer of medical technology, launched the SoftFlow High-Flow Nasal Cannula Therapy. The innovative integrated airflow generator of the soft flow technology and water reservoir attachment enable continued HFNC treatment of recovering COVID-19 patients in the home and other care settings, eliminating the need for a separate source. The technology, which is offered on the softFlow 50, provides high-flow respiratory assistance to adult patients via a soft nasal cannula by delivering a steady high flow of humidified, warm air or an air/oxygen combination. Additionally, SoftFlow delivers continuous airflow through the nostrils, enabling patients to continue eating, drinking, and speaking, which is challenging with mask-based types of respiratory support.
The high flow nasal cannula market report table of contents includes:
- Executive Summary
- Market Characteristics
- Market Trends And Strategies
- Impact Of COVID-19
- Market Size And Growth
- Segmentation
- Regional And Country Analysis
.
.
.
- Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
